Astrana Health (NASDAQ:ASTH) Shares Gap Up – Here’s Why

Astrana Health, Inc. (NASDAQ:ASTH) shares gapped up before the market opened on Tuesday . The stock had previously closed at $29.29, but opened at $32.00. Astrana Health shares last traded at $32.09, with a volume of 35,865 shares traded.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on ASTH shares. Macquarie upgraded Astrana Health to a “hold” rating in a research report on Monday, December 16th. Robert W. Baird dropped their price objective on shares of Astrana Health from $86.00 to $50.00 and set an “outperform” rating for the company in a report on Monday, March 3rd. Bank of America dropped their price target on shares of Astrana Health from $55.00 to $49.00 and set a “buy” rating for the company in a research note on Tuesday, March 4th. Stifel Nicolaus lowered their price objective on Astrana Health from $70.00 to $56.00 and set a “buy” rating for the company in a research report on Thursday, February 20th. Finally, Truist Financial reduced their target price on Astrana Health from $50.00 to $46.00 and set a “buy” rating on the stock in a research report on Tuesday, March 18th. Three research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, Astrana Health has a consensus rating of “Moderate Buy” and a consensus target price of $53.29.

Astrana Health Stock Up 0.9 %

The business’s fifty day moving average is $32.47 and its two-hundred day moving average is $40.18. The stock has a market cap of $1.61 billion, a price-to-earnings ratio of 24.78, a PEG ratio of 1.37 and a beta of 1.04. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) earnings per share for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.37). Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The company had revenue of $665.21 million for the quarter, compared to analysts’ expectations of $617.24 million. Equities analysts forecast that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Institutional Trading of Astrana Health

A number of large investors have recently made changes to their positions in ASTH. Handelsbanken Fonder AB lifted its stake in Astrana Health by 4.7% in the fourth quarter. Handelsbanken Fonder AB now owns 8,900 shares of the company’s stock worth $281,000 after acquiring an additional 400 shares during the last quarter. Quarry LP lifted its position in shares of Astrana Health by 35.5% during the 4th quarter. Quarry LP now owns 1,799 shares of the company’s stock worth $57,000 after purchasing an additional 471 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Astrana Health by 3.9% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 24,505 shares of the company’s stock worth $773,000 after purchasing an additional 915 shares in the last quarter. Swiss National Bank raised its stake in Astrana Health by 1.1% in the fourth quarter. Swiss National Bank now owns 88,444 shares of the company’s stock valued at $2,789,000 after buying an additional 1,000 shares in the last quarter. Finally, MetLife Investment Management LLC boosted its position in shares of Astrana Health by 4.7% during the 4th quarter. MetLife Investment Management LLC now owns 26,284 shares of the company’s stock worth $829,000 after acquiring an additional 1,173 shares in the last quarter. 52.77% of the stock is currently owned by hedge funds and other institutional investors.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.